Evidence map›Paper›PMID 40903652›Full record

ArticleNature aging2025

The aging factor EPS8 induces disease-related protein aggregation through RAC signaling hyperactivation.

Seda Koyuncu, Yaiza Dominguez-Canterla, Rafael Alis, Nassima Salarzai, Dunja Petrovic, Nuria Flames, David Vilchez

Abstract read
In one paragraph

Article in Nature aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Alterations of actin in aging.Journal of cell science · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Seda KoyuncuInstitute for Integrated Stress Response Signaling, Faculty of Medicine, University Hospital Cologne, Cologne, Germany. skoyunc2@uni-koeln.de.ORCID http://orcid.org/0000-0001-7937-3974
Yaiza Dominguez-CanterlaDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia IBV-CSIC, Valencia, Spain.
Rafael AlisDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia IBV-CSIC, Valencia, Spain.
Nassima SalarzaiInstitute for Integrated Stress Response Signaling, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Dunja PetrovicInstitute for Integrated Stress Response Signaling, Faculty of Medicine, University Hospital Cologne, Cologne, Germany.
Nuria FlamesDevelopmental Neurobiology Unit, Instituto de Biomedicina de Valencia IBV-CSIC, Valencia, Spain.
David VilchezInstitute for Integrated Stress Response Signaling, Faculty of Medicine, University Hospital Cologne, Cologne, Germany. dvilchez@uni-koeln.de.ORCID http://orcid.org/0000-0002-0801-0743

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) EXC 2030-390661388Deutsche Forschungsgemeinschaft (German Research Foundation) VI742/4-2Fritz Thyssen Stiftung (Fritz Thyssen Foundation) 0.22.2.030MNGeneralitat Valenciana (Regional Government of Valencia) CIAICO/2022/195
6 · The paper itself

Abstract

Aging is a major risk factor for neurodegenerative diseases associated with protein aggregation, including Huntington's disease and amyotrophic lateral sclerosis (ALS). Although these diseases involve different aggregation-prone proteins, their common late onset suggests a link to converging changes resulting from aging. In this study, we found that age-associated hyperactivation of EPS8/RAC signaling in Caenorhabditis elegans promotes the pathological aggregation of Huntington's disease-related polyglutamine repeats and ALS-associated mutant FUS and TDP-43 variants. Conversely, knockdown of eps-8 or RAC orthologs prevents protein aggregation and subsequent deficits in neuronal function during aging. Similarly, inhibiting EPS8 signaling reduces protein aggregation and neurodegeneration in human cell models. We further identify the deubiquitinating enzyme USP4 as a regulator of EPS8 ubiquitination and degradation in both worms and human cells. Notably, reducing USP-4 upregulation during aging prevents EPS-8 accumulation, extends longevity and attenuates disease-related changes. Our findings suggest that targeting EPS8 and its regulatory mechanisms could provide therapeutic strategies for age-related diseases.

Indexed as

Adaptor Proteins, Signal TransducingAgingCaenorhabditis elegans ProteinsProtein AggregatesProtein Aggregation, Pathologicalrac GTP-Binding ProteinsSignal TransductionAmyotrophic Lateral SclerosisAnimalsCaenorhabditis elegansHumansHuntington DiseaseUbiquitinationAdaptor Proteins, Signal TransducingCaenorhabditis elegans ProteinsEPS8 protein, humanProtein Aggregatesrac GTP-Binding Proteins

Identifiers

PMID40903652
PMCPMC12443605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.